Manufacturing
Medical Device Manufacturing
M&A Intelligence Hub
Five strategic insights on the medical device manufacturing M&A landscape, applied through the Prime Architecture™ Method and the Battle-Ready Index™.
Typical Revenue (LMM)
$10M–$100M
15–25% EBITDA margins
EBITDA Multiples
7x–14x
Mid-band: 10x
Transferability Risk
LOW
Platform activity: Mature.
The five insights
-
For buy-side · ETA · IS
Buying a Medical Device Manufacturing Business
The Strategic Capacity playbook. Pre-LOI diligence framework, BRI factors, what the financials cannot tell you.
-
For sell-side · Operator CEOs
Selling a Medical Device Manufacturing Business
The architecture of a premium exit. Value Gap math, BRI applied, the 18-month transformation roadmap.
-
For both sides
The Medical Device Mfg Value Gap
How transferable value leaks in medical device manufacturing deals, and the architecture that closes the gap.
-
For acquirers · post-close
Integration in Medical Device Manufacturing Acquisitions
Day-1 through day-365 integration architecture. Where deals fail and the substrate that saves them.
-
For advisors · IBs · lenders
Medical Device Manufacturing M&A Diligence Playbook
The Strategic Capacity diligence layer. Runs alongside QoE. Pre-LOI viable.